Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $577 | $766 | $898 | $1,042 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $78 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $12 | $26 | $42 |
| Total Curr. Assets | $699 | $777 | $924 | $1,084 |
| Property Plant & Equip (Net) | $4 | $8 | $11 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,651 | $1,903 | $2,154 | $2,406 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,655 | $1,910 | $2,166 | $2,421 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,354 | $2,687 | $3,090 | $3,505 |
| Liabilities | – | – | – | – |
| Payables | $178 | $159 | $94 | $56 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $178 | $159 | $94 | $56 |
| LT Debt | $3,744 | $3,744 | $3,744 | $3,744 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,024 | $4,024 | $4,024 | $0 |
| Total NC Liab. | $7,767 | $7,767 | $7,767 | $7,767 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,946 | $7,926 | $7,861 | $7,823 |
| Equity | – | – | – | – |
| Pref Stock | $1,835 | $1,754 | $1,673 | $1,593 |
| Common Stock | $7 | $7 | $7 | $7 |
| Retained Earnings | -$19,812 | -$19,479 | -$18,933 | -$18,402 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $4,024 | $4,024 | $0 |
| Total Equity | -$5,592 | -$5,239 | -$4,771 | -$4,319 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,354 | $2,687 | $3,090 | $3,505 |
| Net Debt | $3,167 | $2,978 | $2,846 | $2,701 |